FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

725789008: Carbidopa monohydrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3445284012 Carbidopa monohydrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3445285013 Carbidopa monohydrate en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa monohydrate Is a Carbidopa false Inferred relationship Existential restriction modifier
Carbidopa monohydrate Has disposition Dopamine receptor agonist true Inferred relationship Existential restriction modifier
Carbidopa monohydrate Has disposition Dihydroxyphenylalanine decarboxylase inhibitor true Inferred relationship Existential restriction modifier
Carbidopa monohydrate Is a Dihydroxyphenylalanine true Inferred relationship Existential restriction modifier
Carbidopa monohydrate Is modification of Carbidopa true Inferred relationship Existential restriction modifier
Carbidopa monohydrate Is a Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-careldopa 10mg/40mg/5ml oral suspension (Special Order) 1 ml Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 10mg/40mg/5ml oral suspension Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension (Special Order) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension (Special Order) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (A A H Pharmaceuticals Ltd) 90 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Alliance Healthcare (Distribution) Ltd) 90 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Zentiva Pharma UK Ltd) 90 tablet 9 x 10 tablets Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Somex Pharma) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Somex Pharma) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Somex Pharma) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Somex Pharma) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Somex Pharma) 90 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Somex Pharma) 100 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Somex Pharma) 100 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Somex Pharma) 100 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Icarus Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Icarus Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Niche Pharma Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Niche Pharma Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Waymade Healthcare Plc) 100 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (J M McGill Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (J M McGill Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Lecado 100mg/25mg modified-release tablets (Sandoz Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Lecado 200mg/50mg modified-release tablets (Sandoz Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (AM Distributions (Yorkshire) Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (AM Distributions (Yorkshire) Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Waymade Healthcare Plc) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Ennogen Healthcare Ltd) 50 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Ennogen Healthcare Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (CST Pharma Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Niche Pharma Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Niche Pharma Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Pharma-z Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Pharma-z Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Pharma-z Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Pharma-z Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Apodespan PR 50mg/200mg tablets (Accord Healthcare Ltd) 60 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension 100 ml Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension (Drug Tariff Special Order) 100 ml Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension 1 ml Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension 1 ml Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension (Special Order) 1 ml Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension (Special Order) 1 ml Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Colorama Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Icarus Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Icarus Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (DE Pharmaceuticals) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (DE Pharmaceuticals) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 50 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (DE Pharmaceuticals) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (DE Pharmaceuticals) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (CST Pharma Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Colorama Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 110 tablets (Lexon (UK) Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 275 tablets (Lexon (UK) Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Lexon (UK) Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 110 tablets (Lexon (UK) Ltd) 100 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 275 tablets (Lexon (UK) Ltd) 90 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Lexon (UK) Ltd) 100 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Lexon (UK) Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Lexon (UK) Ltd) 60 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (A A H Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (A A H Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Stephar (U.K.) Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Stephar (U.K.) Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Stephar (U.K.) Ltd) 50 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Stephar (U.K.) Ltd) 100 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 10mg/100mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has specific active ingredient True Carbidopa monohydrate Inferred relationship Existential restriction modifier

Start Previous Page 3 of 4 End


This concept is not in any reference sets

Back to Start